These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3296154)

  • 1. Treatment of keratoconjunctivitis sicca with Lacrisert.
    Prause JU
    Scand J Rheumatol Suppl; 1986; 61():261-3. PubMed ID: 3296154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.
    Sand BB; Marner K; Norn MS
    Acta Ophthalmol (Copenh); 1989 Apr; 67(2):181-3. PubMed ID: 2658462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca.
    Solomon A; Merin S
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):497-504. PubMed ID: 9867333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome.
    Gündüz K; Ozdemir O
    Acta Ophthalmol (Copenh); 1994 Aug; 72(4):438-42. PubMed ID: 7825408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label crossover study of vitamin A ointment as a treatment for keratoconjunctivitis sicca.
    Gilbard JP; Huang AJ; Belldegrun R; Lee JS; Rossi SR; Gray KL
    Ophthalmology; 1989 Feb; 96(2):244-6. PubMed ID: 2704543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group.
    Nelson JD; Gordon JF
    Am J Ophthalmol; 1992 Oct; 114(4):441-7. PubMed ID: 1415455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
    Chen T; Powell CC
    Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydroxypropylmethyl-containing eyedrops in the treatment of sicca syndrome].
    Török M
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):60-2. PubMed ID: 4068574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis.
    Hill JC
    Br J Ophthalmol; 1989 Feb; 73(2):151-4. PubMed ID: 2649149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative clinical study of tear substitutes in normal subjects and in patients with keratoconjunctivitis sicca.
    Marner K; Prause JU
    Acta Ophthalmol (Copenh); 1984 Feb; 62(1):91-5. PubMed ID: 6202090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tear break-up time, Schirmer's-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca.
    Paschides CA; Kitsios G; Karakostas KX; Psillas C; Moutsopoulos HM
    Clin Exp Rheumatol; 1989; 7(2):155-7. PubMed ID: 2736828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of a severe course of keratoconjunctivitis sicca with eledoisin].
    Jaeger W
    Klin Monbl Augenheilkd; 1988 Feb; 192(2):163-6. PubMed ID: 3283426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial.
    Sheppard JD; Singh R; McClellan AJ; Weikert MP; Scoper SV; Joly TJ; Whitley WO; Kakkar E; Pflugfelder SC
    Cornea; 2013 Oct; 32(10):1297-304. PubMed ID: 23884332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.
    Nelson JD; Farris RL
    Arch Ophthalmol; 1988 Apr; 106(4):484-7. PubMed ID: 2451494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
    Hong S; Kim T; Chung SH; Kim EK; Seo KY
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond.
    Wright P; Cooper M; Gilvarry AM
    Br J Ophthalmol; 1987 Feb; 71(2):161-4. PubMed ID: 3548809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes.
    Limberg MB; McCaa C; Kissling GE; Kaufman HE
    Am J Ophthalmol; 1987 Feb; 103(2):194-7. PubMed ID: 3101502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.